Cargando…

Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation

PURPOSE: Urocortin (Ucn) exerts its actions through activation of two corticotropin-releasing factor receptors (CRFRs), CRFR1 and CRFR2. Involvement of Ucn/CRFR2 system in pathophysiological conditions such as the regulation of angiogenesis and inhibition of proliferation has been already reported....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tezval, Hossein, Jurk, Stefanie, Atschekzei, Farahnaz, Becker, Jan U., Jahn, Olaf, Serth, Jürgen, Kuczyk, Markus A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780655/ https://www.ncbi.nlm.nih.gov/pubmed/19437022 http://dx.doi.org/10.1007/s00345-009-0417-x

Ejemplares similares

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

Regulation of gonadotropins by corticotropin-releasing factor and urocortin
por: Kageyama, Kazunori
Publicado: (2013)

Distribution of Urocortins and Corticotropin-Releasing Factor Receptors in the Cardiovascular System
por: Takahashi, Kazuhiro
Publicado: (2012)

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
por: Tezval, Hossein, et al.
Publicado: (2008)

Corticotropin-releasing Factor (CRF) and Urocortin Promote the Survival of Cultured Cerebellar GABAergic Neurons Through the Type 1 CRF Receptor
por: Choi, Jae-Sun, et al.
Publicado: (2006)

Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus
por: Chen, Peilin, et al.
Publicado: (2013)

Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Entero-pathy in Rats
por: Takeuchi, Koji, et al.
Publicado: (2016)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
por: PETERS, INGA, et al.
Publicado: (2014)

Differentiation dependent expression of urocortin’s mRNA and peptide in human osteoprogenitor cells: influence of BMP-2, TGF-beta-1 and dexamethasone
por: Tezval, Mohammad, et al.
Publicado: (2009)

Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin
por: Saul, Dominik, et al.
Publicado: (2019)

Corticotropin-releasing Hormone and Its Biological Diversity toward Angiogenesis
por: Im, Eunok
Publicado: (2014)

Multi-facets of Corticotropin-releasing Factor in Modulating Inflammation and Angiogenesis
por: Im, Eunok
Publicado: (2015)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021)

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
por: Dubrowinskaja, Natalia, et al.
Publicado: (2014)

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer
por: Waalkes, Sandra, et al.
Publicado: (2010)

Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)
por: Serth, Jürgen, et al.
Publicado: (2022)

Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure
por: Stirrat, Colin G., et al.
Publicado: (2016)

PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both
por: Tezval, Hossein, et al.
Publicado: (2021)

Urocortins in the mammalian endocrine system
por: Squillacioti, Caterina, et al.
Publicado: (2019)

The Role of Urocortins in Intracerebral Hemorrhage
por: Choy, Ker Woon, et al.
Publicado: (2020)

Exploring the Role of Urocortin in Osteoporosis
por: Ismail, Omar M, et al.
Publicado: (2023)

Linking stress with urocortin in rats
por: Balraj, Manikandan, et al.
Publicado: (2023)

Effects of Urocortin 2 Versus Urocortin 3 Gene Transfer on Left Ventricular Function and Glucose Disposal
por: Giamouridis, Dimosthenis, et al.
Publicado: (2018)

Role of Corticotropin-releasing Factor in Gastrointestinal Permeability
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2015)

Central corticotropin releasing factor and social stress
por: Backström, Tobias, et al.
Publicado: (2013)

Endocrinology and the brain: corticotropin-releasing hormone signaling
por: Inda, Carolina, et al.
Publicado: (2017)

Corticotropin-Releasing Hormone: Biology and Therapeutic Opportunities
por: Caruso, Alessandra, et al.
Publicado: (2022)

Regulation and Roles of Urocortins in the Vascular System
por: Kageyama, Kazunori, et al.
Publicado: (2012)

New targets of urocortin-mediated cardioprotection
por: Barry, Seán P, et al.
Publicado: (2010)

Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature
por: Kramer, Mario W., et al.
Publicado: (2012)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

Organization of the corticotropin‐releasing hormone and corticotropin‐releasing hormone‐binding protein systems in the central nervous system of the sea lamprey Petromyzon marinus
por: Sobrido‐Cameán, Daniel, et al.
Publicado: (2022)

On the role of corticotropin-releasing hormone receptors in anxiety and depression
por: Reul, Johannes M. H. M., et al.
Publicado: (2002)

Conformational thermostabilisation of corticotropin releasing factor receptor 1
por: Kean, James, et al.
Publicado: (2015)

Metabolic Association between Leptin and the Corticotropin Releasing Hormone
por: Gioldasi, Sofia, et al.
Publicado: (2019)

Stress Adaptation and the Brainstem with Focus on Corticotropin-Releasing Hormone
por: Chaves, Tiago, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4vnrj3uspqhpqmj44tg4p2oa0r